Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Raben

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 10, 2019
Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP)S Peters, U Dafni, M Boyer, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 2001
Radiation Therapy Oncology Group. Research Plan 2002-2006. Gastrointestinal Cancer CommitteeC Willett, J Ajani, D Kelsen, et al.
HIV Medicine|October 25, 2019
The EuroSIDA study: 25 years of scientific achievementsK Laut, O Kirk, J Rockstroh, et al.
Plos One|November 13, 2015
Auditing HIV Testing Rates across Europe: Results from the HIDES 2 StudyD Raben, A Mocroft, M Rayment, et al.
HIV Medicine|September 17, 2013
Comparison of two HIV testing strategies in primary care centres: indicator-condition-guided testing vs. testing of those with non-indicator conditionsI Menacho, E Sequeira, M Muns, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 10, 2019
Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP)S Peters, U Dafni, M Boyer, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 2001
Radiation Therapy Oncology Group. Research Plan 2002-2006. Gastrointestinal Cancer CommitteeC Willett, J Ajani, D Kelsen, et al.
HIV Medicine|October 25, 2019
The EuroSIDA study: 25 years of scientific achievementsK Laut, O Kirk, J Rockstroh, et al.
Plos One|November 13, 2015
Auditing HIV Testing Rates across Europe: Results from the HIDES 2 StudyD Raben, A Mocroft, M Rayment, et al.
HIV Medicine|September 17, 2013
Comparison of two HIV testing strategies in primary care centres: indicator-condition-guided testing vs. testing of those with non-indicator conditionsI Menacho, E Sequeira, M Muns, et al.
Pageof 5